MediPal Holdings Corp (MAHLY) distributes pharmaceuticals and health and beauty products to medical institutions and retailers.The firm operates in three segments: (1) prescription pharmaceutical wholesale; (2) cosmetics, daily necessities, and OTC pharmaceutical wholesale; and (3) animal health products wholesale.The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies.The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets.The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives.Medipal Holdings generates the vast majority of its revenue in Japan.The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009.The company was founded in 1898 and is headquartered in Tokyo, Japan.Three key data points gauge MediPal Holdings Corp. or any dividend-paying firm.The key three are:(1) Price(2) Dividends(3) ReturnsThose three basic keys best tell whether any company has made, is making, and will make money.MAHLY PriceOver the past year, MediPal share price fell about 9.4% from $15.56 to $15.22 as of Wednesday’s market close.If MediPal shares trade in the range of $14 to $18.00 this next year, its recent $15.22 share price might rise to 15.80 by next year. Of course, MediPal’s price could drop about the same $0.58 estimated amount or more.My annual upside estimate of $0.58 however, is just $0.03 below MediPal’s average annual price gain over the past 12 years.MAHLY DividendMediPal Holdings Corp. has paid variable semi-annual dividends since June 2014, MediPal’s most recent SA dividend of 0.20 was declared 9/21/23 for shareholders of record 9/28/23 and the payout was made 12/18/23.A forward-looking $0.38 annual dividend yields 2.48% at Wednesday’s $15.22 share price.MAHLY ReturnsTo put it all together, add the MediPal’s estimated annual dividend of $0.38. to the estimated price upside of $0.58 to find a $0.96 estimated gross gain for the coming year.At Wednesday’s $15.22 share price, a little over $1000 would buy 66 shares.A $10 broker fee (if charged), paid half at purchase and half at sale, would cost us about $0.15 per share.Subtracting that likely $0.15 brokerage cost from the $0.96 gross gain reveals a net gain of $0.81 X 66 shares = $53.46 for a 5.35% estimated net gain on the year.You might choose to pounce on MediPal Holdings Corp. It is a 126-year-old dividend-paying Tokyo, Japan-based pharmaceutical distribution firm. Furthermore, its estimated $24.80 annual dividend income from $1k invested is over 1.6 times greater than MedPal’s recent $15.22 share price.The exact track of MediPal Holdings Corp’s upcoming future price and dividend will entirely be determined by market action.Remember the true value of any stock is best realized through personal ownership of shares.More By This Author:Current Analysis: Fresenius Medical Care
Current Analysis: Sweden-Based, Elekta AB
Current Analysis: CompuGroup Medical (CMPVF)
